Penumbra Gross Profit 2014-2019 | PEN

Penumbra annual/quarterly gross profit history and growth rate from 2014 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Penumbra gross profit for the quarter ending September 30, 2019 was $0.096B, a 27.98% increase year-over-year.
  • Penumbra gross profit for the twelve months ending September 30, 2019 was $0.353B, a 27.02% increase year-over-year.
  • Penumbra annual gross profit for 2018 was $0.293B, a 34.72% increase from 2017.
  • Penumbra annual gross profit for 2017 was $0.217B, a 27.11% increase from 2016.
  • Penumbra annual gross profit for 2016 was $0.171B, a 37.7% increase from 2015.
Penumbra Annual Gross Profit
(Millions of US $)
2018 $293
2017 $217
2016 $171
2015 $124
2014 $83
2013 $58
Penumbra Quarterly Gross Profit
(Millions of US $)
Q3 2019 $96
Q2 2019 $94
Q1 2019 $84
Q4 2018 $79
Q3 2018 $75
Q2 2018 $72
Q1 2018 $67
Q4 2017 $64
Q3 2017 $55
Q2 2017 $51
Q1 2017 $48
Q4 2016 $47
Q3 2016 $43
Q2 2016 $41
Q1 2016 $40
Q4 2015 $36
Q3 2015 $33
Q2 2015 $27
Q1 2015 $27
Q4 2014
Q3 2014 $21
Q4 2013
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.599B $0.445B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $136.012B 28.17
Intuitive Surgical (ISRG) United States $69.348B 54.50
Edwards Lifesciences (EW) United States $49.773B 45.20
IDEXX Laboratories (IDXX) United States $24.517B 59.29
Fresenius Medical Care AG KGaA (FMS) Germany $22.773B 15.41
Olympus (OCPNY) Japan $22.330B 167.69
DexCom (DXCM) United States $21.124B 189.17
Teleflex (TFX) United States $17.765B 36.06
SONOVA HOLDING (SONVY) Switzerland $15.277B 0.00
Sysmex ADR (SSMXY) Japan $14.597B 39.29
Hologic (HOLX) United States $14.566B 22.26
Varian Medical Systems (VAR) United States $13.545B 32.11
STERIS (STE) Ireland $13.068B 28.86
Masimo (MASI) United States $9.053B 54.06
ABIOMED (ABMD) United States $8.186B 44.54
SARTORIUS AG (SARTF) Germany $6.731B 59.08
Globus Medical (GMED) United States $5.299B 32.70
Integra LifeSciences Holdings (IART) United States $5.077B 21.82
Elekta AB (EKTAY) Sweden $4.535B 38.29
Tandem Diabetes Care (TNDM) United States $4.053B 0.00
Wright Medical Group (WMGI) Netherlands $3.820B 231.54
Nevro (NVRO) United States $3.752B 0.00
LivaNova (LIVN) United Kingdom $3.547B 25.53
Integer Holdings (ITGR) United States $2.909B 19.92
Cantel Medical (CMD) United States $2.659B 26.02
Nihon Kohden (NHNKY) Japan $2.458B 24.73
Glaukos (GKOS) United States $2.088B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.588B 31.26
Veracyte (VCYT) United States $1.473B 0.00
Silk Road Medical (SILK) United States $1.322B 0.00
Natus Medical (NTUS) United States $1.170B 28.14
Mesa Laboratories (MLAB) United States $1.159B 42.97
Tactile Systems Technology (TCMD) United States $1.157B 132.22
CryoLife (CRY) United States $1.125B 115.35
Inogen (INGN) United States $1.087B 34.33
Luminex (LMNX) United States $1.044B 0.00
OPKO Health (OPK) United States $1.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.945B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.894B 29.71
OrthoPediatrics (KIDS) United States $0.799B 0.00
Intersect ENT (XENT) United States $0.771B 0.00
Pacific Biosciences Of California (PACB) United States $0.762B 0.00
Quotient (QTNT) Switzerland $0.686B 0.00
AngioDynamics (ANGO) United States $0.582B 26.69
AxoGen (AXGN) United States $0.565B 0.00
Si-Bone (SIBN) United States $0.544B 0.00
Alphatec Holdings (ATEC) United States $0.456B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.427B 12.92
Sientra (SIEN) United States $0.379B 0.00
Semler Scientific (SMLR) United States $0.327B 45.46
RTI Surgical (RTIX) United States $0.326B 88.20
ViewRay (VRAY) United States $0.310B 0.00
SeaSpine Holdings (SPNE) United States $0.303B 0.00
IRadimed (IRMD) United States $0.301B 42.34
Fluidigm (FLDM) United States $0.294B 0.00
Accuray (ARAY) United States $0.292B 0.00
GenMark Diagnostics (GNMK) United States $0.288B 0.00
Restoration Robotics (VERO) Canada $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.127B 0.00
EDAP TMS S.A (EDAP) France $0.119B 31.54
ConforMIS (CFMS) United States $0.087B 0.00
Neuronetics (STIM) United States $0.082B 0.00
Vermillion (VRML) United States $0.078B 0.00
Second Sight Medical Products (EYES) United States $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Bioanalytical Systems (BASI) United States $0.063B 0.00
Apollo Endosurgery (APEN) United States $0.060B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.038B 0.00
Helius Medical Technologies (HSDT) United States $0.034B 0.00
Neovasc (NVCN) Canada $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.009B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00